IDEA-033 Open Label Study
NCT00372333
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
491
Enrollment
INDUSTRY
Sponsor class
Conditions
Joint Pain
Musculoskeletal Pain
Stiffness
Soft Tissue Inflammation in Designated Target Area(s)
Interventions
DRUG:
IDEA-033
Sponsor
IDEA AG